/

Other

/

Aquestive Therapeutics

Aquestive Therapeutics

Aquestive Therapeutics

Verified Nov 2026

Other

·

United States flag

Warren, New Jersey

·

Since 2005

Aquestive Therapeutics is a specialty pharmaceutical company founded in 2005 and headquartered in Warren, New Jersey, with 100–200 employees and estimated revenue of $10–50 million. The company develops and commercializes medicines using proprietary thin-film drug-delivery technologies for neurological and allergy conditions. It serves medical and pharmaceutical markets, with five commercialized products including Sympazan for seizures and Libervant for seizure clusters, and operates manufacturing facilities in New Jersey and Indiana.

Aquestive Therapeutics

Verified Nov 2026

AT A GLANCE

Founded

2005

Headquarters

United States flag

Warren, New Jersey

Employees

100-200

Ownership

Aquestive Therapeutics at a glance

Revenue

$10-50M

Est. band

Employees

100-200

Founded

2005

Headquarters

Warren, New Jersey

Industries

Automotive

Electric Vehicles

Medical

Overview

Aquestive Therapeutics is a specialty pharmaceutical company founded in 2005 and headquartered in Warren, New Jersey, with 100–200 employees and estimated revenue of $10–50 million. The company develops and commercializes medicines using proprietary thin-film drug-delivery technologies for neurological and allergy conditions. It serves medical and pharmaceutical markets, with five commercialized products including Sympazan for seizures and Libervant for seizure clusters, and operates manufacturing facilities in New Jersey and Indiana.

At a glance

Attribute

Detail

Founded

2005

Headquarters

Warren, New Jersey

Employees

100-200

Revenue

$10-50M (estimated)

What Aquestive Therapeutics makes

The company's PharmFilm and AdrenaVerse platforms deliver medications through oral soluble, buccal, or sublingual films, including a needle-free epinephrine treatment for anaphylaxis in late-stage development.

Latest developments

Facilities

Aquestive Therapeutics is headquartered in Warren, New Jersey. Public sources also reference these locations:

Company details

Aquestive completed a $150 million debt refinancing with Oaktree Capital in May 2026 to support operations and product commercialization. Aquestive Therapeutics was founded in 2005, has an estimated 100-200 employees, and is headquartered in Warren, New Jersey.

Frequently asked questions

What does Aquestive Therapeutics do?

Aquestive Therapeutics is a specialty pharmaceutical company founded in 2005 and headquartered in Warren, New Jersey, with 100–200 employees and estimated revenue of $10–50 million. The company develops and commercializes medicines using proprietary thin-film drug-delivery technologies for neurological and allergy conditions. It serves medical and pharmaceutical markets, with five commercialized products including Sympazan for seizures and Libervant for seizure clusters, and operates manufacturing facilities in New Jersey and Indiana.

Where is Aquestive Therapeutics headquartered?

Aquestive Therapeutics is headquartered in Warren, New Jersey (30 Technology Drive South, Warren, New Jersey, 07059).

When was Aquestive Therapeutics founded?

Aquestive Therapeutics was founded in 2005.

How big is Aquestive Therapeutics?

Aquestive Therapeutics has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Warren, New Jersey (HQ)Headquarters · United States
Warren, New Jersey (HQ)30 Technology Drive South, Warren, New Jersey, 07059, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.